HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yojiro Maehata Selected Research

2,7,12,17-tetraphenylporphycene

10/2017TRPM5 mediates acidic extracellular pH signaling and TRPM5 inhibition reduces spontaneous metastasis in mouse B16-BL6 melanoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yojiro Maehata Research Topics

Disease

8Neoplasms (Cancer)
04/2019 - 09/2006
5Neoplasm Metastasis (Metastasis)
04/2019 - 01/2012
4Squamous Cell Carcinoma of Head and Neck
01/2014 - 11/2009
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 11/2009
2Periodontitis
03/2016 - 01/2006
2Stroke (Strokes)
03/2016 - 09/2008
2Fibrosarcoma
01/2014 - 01/2012
2Down Syndrome (Down's Syndrome)
09/2013 - 01/2006
2Carcinoma (Carcinomatosis)
01/2012 - 09/2006
1Carcinogenesis
04/2019
1Bisphosphonate-Associated Osteonecrosis of the Jaw
01/2019
1Osteonecrosis (Kienbock's Disease)
01/2019
1Experimental Melanoma
10/2017
1Stomach Neoplasms (Stomach Cancer)
10/2017
1Melanoma (Melanoma, Malignant)
10/2017
1Hyperemia
03/2016
1Macular Degeneration (Age-Related Maculopathy)
12/2013
1Hypoxia (Hypoxemia)
09/2013
1Infections
06/2012
1Periodontal Diseases (Periodontal Disease)
06/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2009
1Brain Injuries (Brain Injury)
09/2008
1Brain Diseases (Brain Disorder)
09/2008

Drug/Important Bio-Agent (IBA)

6ChemokinesIBA
04/2019 - 09/2006
5Reactive Oxygen Species (Oxygen Radicals)IBA
12/2013 - 01/2006
2LigandsIBA
04/2019 - 08/2010
2Proteins (Proteins, Gene)FDA Link
04/2019 - 01/2014
2Messenger RNA (mRNA)IBA
10/2017 - 01/2014
2fasudil (AT 877)IBA
01/2014 - 01/2012
2AntioxidantsIBA
06/2012 - 09/2008
2Hydroxyl RadicalIBA
08/2010 - 09/2008
2Epidermal Growth Factor (EGF)IBA
11/2009 - 09/2006
1CateninsIBA
01/2019
1Alendronate (Alendronate Sodium)FDA LinkGeneric
01/2019
1triphenylphosphine oxideIBA
10/2017
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2017
12,7,12,17-tetraphenylporphyceneIBA
10/2017
1Monovalent CationsIBA
10/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2016
1AntibodiesIBA
03/2015
1rho-Associated KinasesIBA
01/2014
1SymportersIBA
09/2013
1Proton-Translocating ATPases (ATPase, H+)IBA
09/2013
1EnzymesIBA
09/2013
1Lactic Acid (Lactate)FDA LinkGeneric
09/2013
1Proton Pumps (Proton Pump)IBA
09/2013
1Biomarkers (Surrogate Marker)IBA
09/2013
1Protein Kinases (Protein Kinase)IBA
01/2012
1Monomeric GTP-Binding ProteinsIBA
01/2012
1Interleukin-8 (Interleukin 8)IBA
08/2010
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
08/2010
1CXC ChemokinesIBA
08/2010
1Gefitinib (Iressa)FDA Link
11/2009
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2009
1ErbB Receptors (EGF Receptor)IBA
11/2009
1Pharmaceutical PreparationsIBA
11/2009
1Propofol (Diprivan)FDA LinkGeneric
09/2008
1nitroxylIBA
09/2008
1Triglycerides (Triacylglycerol)IBA
09/2008
1IronIBA
01/2006
1Superoxide DismutaseIBA
01/2006

Therapy/Procedure

1Aftercare (After-Treatment)
01/2019
1Low-Level Light Therapy (LLLT)
01/2019
1Lasers (Laser)
03/2016
1Therapeutics
01/2012
1Oral Administration
11/2009
1Craniotomy
09/2008
1Anesthesia
09/2008